RNA's Advantages Over Other Cell Therapies with Cartesian's CSO

Cell & Gene: The Podcast

English - January 06, 2022 09:00 - 19 minutes - 13.7 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells

Next Episode: Cellevolve Bio's Dr. Derrell Porter on the Need for Diversity and Inclusion in Biotech

We love to hear from our listeners. Send us a message.

Dr. Michael Singer, CSO at Cartesian Therapeutics, details why RNA has advantages over other cell therapies, the company's three RNA trials, and the therapeutic benefit of multiple modifications.